Mod GRF 1-29 Peptide: Investigating Its Potential in Scientific Research
The Mod GRF 1-29 peptide has garnered attention in scientific research due to its hypothesized role in regulating growth hormone. As a modified analog...
MGI Tech and JCBio Advance Multi-Omics with DCS Lab Project
MGI Tech Co., Ltd., a developer of advanced life sciences technologies, and JCBio Co., Ltd., a biotechnology company in South Korea, have entered into...
Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug
Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into neuroscience drug development. The...
FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment
Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...
FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia
The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...
U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema
Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...
Roche’s Genentech Launches New Manufacturing Facility in USA
Genentech, part of the Roche Group, has broken ground on its latest US manufacturing facility in Holly Springs, North Carolina. The development represents the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...